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ABSTRACT
OBJECTIVE: The objective of this selective evidence-based medicine (EBM) review is to
determine whether or not “Is an endoscopic thoracic sympathectomy (ETS) at the T2 level
effective in resolving palmar hyperhidrosis and resulting in patient satisfaction?”
STUDY DESIGN: Systematic review of three randomized control trials published in 2009,
2016, and 2017, all in the English language. Studies were analyzed and reviewed based on
population, intervention, and outcomes measured.
DATA SOURCES: Three randomized controlled trials where all published in peer-reviewed
journals and researched using the PubMed and CINAHL databases.
OUTCOMES MEASURED: All three studies measured the presence or absence of palmar
hyperhidrosis (PH) and/or compensatory hyperhidrosis (CH) via patient report and physical
examination. All studies also measured patient satisfaction through patient questionnaires.
RESULTS: All patients in the studies except one showed immediate anhidrosis postoperatively
and no PH recurrence. Despite great initial postoperative results, many patients developed CH
symptoms. Patient satisfaction rate was high in all three articles reviewed.
CONCLUSIONS: The results from this systemic review suggest an endoscopic thoracic
sympathectomy (ETS) at the T2 level is adequately effective in resolving palmar hyperhidrosis
and resulting in patient satisfaction.
KEY WORDS: Sympathectomy, Hyperhidrosis, Randomized Control Trial
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INTRODUCTION
Palmar hyperhidrosis (PH) is an excessive, uncontrollable, sweating of the hands. PH
occurs equally in both genders and can be present at any age, but tends to affect adolescents and
young adults most often due to the increased activation of eccrine sweat glands during puberty.1,2
In the US, 15.3 million individuals are estimated to be living with hyperhidrosis on varying
bilateral cutaneous body regions, with 0.3-4.5% of the general population having the condition
confined to just their palms.2,3 There is increasing evidence for a genetic component to the
condition since most patients present with a family history.1 The sweating is thought to be caused
by a benign, idiopathic hyperfunctioning of the sympathetic nervous system in thermoregulation
of the body in response to normal heat or exercise.1 The excessive diaphoresis can seriously
disrupt a person’s daily professional, emotional, and social lives potentially leading to lost
opportunities and problems of a psychosocial nature.4
Many patients learn to live with their condition despite the effect it has on their quality of
life as they do not realize it is treatable. The small group that do seek treatment usually do so
through a dermatologist who may initially suggest a number of creams, lotions, or antiperspirants
for the patient.5 Patents can also receive Botox injections, microwave therapy, or an endoscopic
thoracic sympathectomy (ETS).4 The total healthcare cost of PH has not been identified since
treatments and their expense vary greatly. Certain over the counter options can cost $8-20,
whereas more aggressive treatments, such as surgery, can cost up to $20,000.3 Additional
expenses include frequent new clothing, dry cleaning, and other specific absorbent pads, towels,
or fabrics for daily disease management. Many conservative treatments for palmer hyperhidrosis
are found to be unsuccessful and unsatisfactory, leading some patients to instead opt for the more
definitive solution of surgery.2 Currently, the ETS is the most effective and definitive therapeutic
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approach to the treatment of PH.1 The specific neural ganglion level of the ETS performed is still
debated by the medical community.6
OBJECTIVE
The objective of this selective EBM review is to determine whether or not “Is an endoscopic
thoracic sympathectomy (ETS) at the T2 level effective in resolving palmar hyperhidrosis and
resulting in patient satisfaction?”
METHODS
In this selective evidence-based medicine (EBM) review, three randomized control
studies were analyzed and reviewed based on population, intervention, and outcomes measured.
The population includes adults or young adults with palmar hyperhidrosis. Experimental
intervention reviewed was an ETS at T2 and compared to ETS at other levels (T31,2, T2-T36). All
patients that participated in the study were blind as to which ganglion level their EST surgery
was being performed at. The degree of patient satisfaction with relation to resolution,
reoccurrence, incidence, or severity of PH or compensatory hyperhidrosis (CH) were the
measured outcomes.
The three articles studied were published in peer reviewed journals, selected using the
research databases of PubMed or CINAHL, all written in English, and dated from 2009-2017.
Keywords used in the searches included “hyperhidrosis,” “sympathectomy,” and “randomized
control trial.” Articles where chosen based on their relevance and inclusion of patient-oriented
outcomes (POEMS). Other inclusion criteria were full text RCT studies done on humans
published after the year 2008. Exclusion criteria included systematic reviews published before
2008 and any animal studies. These three studies reported statistics as NNT, EER, CER, RBI,
ABI, and/or p values. Characteristics of each study are outlined in Table 1.
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Table 1. Demographics & Characteristics of Included Studies
Study

Type
RCT

#
Pts
60

Age
(yrs)
1630

Inclusion
Criteria
Those with
PH,
otherwise
healthy

Yazbek1
(2009)

Turkyilmaz2
(2017)

RCT

50

1728

Ong6 (2016)

RCT

39

1458

Patients who
felt
handicapped
due to PH
and in which
conservative
treatments
had failed
Patient with
PH

Exclusion Criteria

W/D

Interventions

“patients with prior
thoracic surgery,
cardiac diseases,
pulmonary infection,
neoplasia or pleural
or lung diseases that
could increase
surgical risk, or with
a body mass index
(BMI) greater than
25”1
Not reported

3

ETS at
denervation
level of T2
VS. T3
ganglion

0

ETS at level
of T2 VS. T3

Those with secondary
causes of PH:
hyperthyroidism,
chronic infections,
malignancy, and
immunological
disorders6

17

ETS at single
level T2 VS.
multi-level
T2-T3
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OUTCOMES MEASURED
The primary outcome measured in all three studies was the presence or absence of PH
and/or compensatory hyperhidrosis (CH) via patient report and physical examination of patients
who were originally diagnosed with PH. All studies also measured patient satisfaction through
questionnaires, though questionnaires varied between the studies.
RESULTS
All three randomized control studies compared two groups that underwent ETS and
resulted in no mortality.1,2,6 Two studies had one group receive bilateral ETS at ganglion level of
T2, while the other group’s ETS were completed at the T3 level.1,2 In the third study all patients
undergoing ETS received a T2 level ablation on one side of the body and a combined T2-T3
level ablation on the other side, with the two groups differing in which side of the body was used
for each ETS ganglion level type.6 Patients were selected randomly for their group of treatment
and all blind to the ETS level preformed in all studies. Demographics, inclusion criteria, and
exclusion criteria for all the studies can be seen in Table 1.
In the Yazbek et al.1 study each group equally consisted of 30 patients. Patients had five
clinical assessments through the study to assess for palmar anhidrosis, CH, and patient degree of
satisfaction using the quality-of-life protocol classifying satisfaction into five levels.1 Three
patients (5%) were lost from the study during follow up and not included in later assessments.1
The baseline assessment, in the immediate postoperative period, found all patients reported
anhidrosis.1 Only one patient in the T3 group denied anhidrosis at the next assessment 1 week
after surgery; they had a second negative outcome following a repeat surgery and was deemed a
case of “therapeutic failure.”1 At the subsequent three return assessments at one month, six
months, and between 12-34 (mean of 20) months post-surgery all other patients continued to
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have no PH recurrence.1 This study resulted in varying severity of CH for all patients of both
groups by the final assessment postoperatively as seen in Table 2. Association between ETS
level and surgery results or complications were investigated using the chi-square of Fisher exact
test.1 The patient who experienced a “therapeutic failure,” was not included in the last two
assessments for CH due to the timeline coinciding with their repeat surgery.1 The two compared
procedures at T2 or T3 were not statistically significant for either producing a lessor rate of CH
presence compared to each other, but the T3 procedure was statistically significant in resulting in
a non-severe form of CH instead of severe CH compared to the T2 procedure at all three later
postoperative.1 The quality-of-life protocol measured patient satisfaction by classifying a
summed total score of the questionnaire completed by patients into five levels based on
“situations in daily life in which hyperhidrosis might interfere,” seen in Table 3.1 On average, in
both groups, all patients’ quality-of-life was considered very poor preoperatively, then improved
to excellent in all those still able to be assessed postoperatively. There was no statistically
significant improvement in quality of life and therefore patient satisfaction with the procedure
done at T2 as compared to T3.1
Table 2. CH Presence and Severity After ETS as Measured by Yazbek et at.1 2009
1 month
6 months
20 months
T2:T3
p value
T2:T3
p value
T2:T3
Without CH
4:3
0:1
0:0
>0.999
NA
With CH total
26:27
30:29
28:29
Non-severe CH 16:27
20:26
15:25
<0.001
=0.033
Severe CH
10:0
10:3
13:4
NA: couldn’t evaluate; CH compensatory hyperhidrosis; p-value <0.05 statistically significant

p value
NA
=0.007

Table 3. Patient Satisfaction Total Scores of Quality-of-Life Protocol by Yazbek et at.1
2009
T2
T3
p value
1 week preop (median)
92 (67-100) Very Poor
87.5 (75-100) Very Poor
0.3052
1 month postop (median)
23 (20-47) Excellent
23 (20-42) Excellent
0.8423
6 month postop (median)
24 (20-56) Excellent
24 (19-52) Excellent
0.3905
20 month postop (median) 26 (20-52) Excellent
29 (21-43) Excellent
0.7609
Total score range of 20-100; Score >84 as Very Poor, 69-84 as Poor, 52-68 as Good, 36-51 as Very Good, and 2035 as Excellent; p-value <0.05 statistically significant
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In the Turkyilmaz et al.2 study, each group equally consisted of 25 patients. All patients
in both groups presented with palmar anhidrosis immediately after surgery.2 All subjects were
interviewed, assessed, and physically examined for PH recurrence, CH, and patient satisfaction
postoperatively at 1 month and 10-16 months (median 13) with no loss to follow up.2 No
recurrence of PH occurred to any subjects during this study, nor any CH within the first month.2
At one year follow up, three patients in the group T2 ETS and two from the T3 ETS group
exhibited signs of CH on the back or abdomen, though only one subject from group T2 found
their symptoms to be severe leading to dissatisfaction of the procedure performed.2 Overall both
groups experienced high patient satisfaction rates throughout the study with their specific scoring
found in Table 4. Using the chi-square test comparisons, neither CH or patient satisfaction rates
were found to be statistically significant between the two ETS ablation level groups (p values:
0.637 and 0.203 respectively; p-value <0.05 statistically significant).2
Table 4. Patient Satisfaction Scoring by Turkyilmaz et al.2 2017

1 month
Median 13
months

Satisfaction:

Excellent

Satisfactory

Unsatisfactory

T2 (n=25)
T3 (n=25)

25 (100%)
25 (100%)

0
0

0
0

Total
Patient
Satisfaction
100%
100%

T2 (n=25)

22 (88%)

2 (8%)

1 (4%)

96%

4%

T3 (n=25)

23 (92%)

2 (8%)

0

100%

0

Total Patient
Dissatisfaction
0
0

In the long-term Ong et al.6 study 25 of the 39 patients had their combined T2-T3 ETS on
the right side and the single T2 ETS on their left side of the body. The other 14 patients had the
same procedures preformed on opposite sides. Immediately after surgery, all 39 patients
exhibited anhidrosis of the palms bilaterally.6 Twelve patients (43.6%) were lost in the years
following procedure.6 An observer, who was also blind to the ganglion level of each patient’s
procedure, assessed all the remaining patients via telephone interview for any PH recurrence,
CH, and patient satisfaction.6 To compare T2 single level verse T2–T3 multi-level ablation, “the
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level of sympathectomy on one side was matched to the ipsilateral recurrence of palmar
hyperhidrosis, the site and the severity of compensatory sweating for body parts that were not
found in the midline (axilla and lower limbs specifically).”6 This study followed the International
Hyperhidrosis Society’s disease severity scale but used a grade system instead of points.6 Four of
the 22 patients successfully contacted later in the study had developed a recurrence of PH
bilaterally, though it was milder than their preoperative symptoms.6 Twenty patients experienced
some bilateral CH in varying forms and found the most common site of CH to be the trunk.6 For
patients experiencing PH and/or CH there was, “no absolute difference in the severity of
sweating,” between the two ETS group levels.6 Overall, 16 of the 22 final study participants were
satisfied with their ETS results.6 Those that were not satisfied in the Ong et al.6 study reported it
being due to forms of PH recurrence in 2 patients or CH in 4 patients. Similarly, patient
satisfaction was also not found to be significantly higher in one ETS group than the other. All
results for Ong et al.6 found in Table 5.
Table 5. Long-term Clinical Outcomes of Both ETS Groups Measured by Ong et al.6 2016
Outcomes

PH
Recurrence

CH

Patient
Satisfaction

Scale

Results (n=22)

Totals (n=22)

No

18 (81.8%)

No

18 (81.8%)

Yes (mild)

2 (9.1%)

Yes (moderate)

0

Yes

4 (18.2%)

Yes (severe)
No
Yes
Very Satisfied
Satisfied
Dissatisfied
Very Dissatisfied

2 (9.1%)
2 (9.1%)
20 (90.9%)
13 (59.2%)
3 (13.6%)
3 (13.6%)
3 (13.6%)

No
Yes

2 (9.1%)
20 (90.9%)

Satisfied

16 (72.8%)

Dissatisfied

6 (27.2%)

Comparisons of all three studies can be seen in Tables 6 and 7. All but one patient in the
three studies experienced immediate postoperative anhidrosis.1,2,6 Specifically, for those with the
T2 level ETS, the surgery was 100% successful in achieving instant anhidrosis. Out of three, a
single study had recurrence and did involve ETS at T2 at a rate of 22%, which was only slightly
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higher than the typical report average of 18%.6 Despite great initial postoperative results, in each
study many patients developed varied CH symptoms across the board with different ranges in
comparison to the usual average of 60%.6 No specific ETS level reviewed was able to
completely avoid the CH effect. Patient satisfaction rate in general and specifically for T2 ETS
was high in all three articles reviewed.1,2,6
Table 6. Treatment Effects on Patient Satisfaction of Included Studies
Study
Yazbek et al.1
CER
0.9655
EER
1.0
RBI
0.0357
ABI
0.0345
NNT
-29
Treatment effect p-value 0.7609
p-value <0.05 statistically significant

Turkyilmaz et al.2
1.0
0.92
0.0417
-0.04
-25
0.203

Ong et al.6
No data due to study data
being presented as
combined not compared
No comment

Table 7. Comparison of Full Final Results of Included Studies and Their T2 Groups
Avg
ETS
postop

Study

Initial
Anhidrosis
PH
recurrence
Final CH
Values
Severe CH

Yazbek et al.1

Turkyilmaz et al.2

Ong et al.6

Full

T2

Full

T2

Full

59/60=98%

30/30=100%

50/50=100%

25/25=100%

39/39=100%

18%6

0/59=0%

0/30=0%

0/50=0%

0/25=0%

4/18=22%

60%6

57/57=100%

28/28=100%

5/50=20%

3/25=12%

20/22=91%

17/57=30%

13/28=46%

0/5=0%

1/3=33%

57/57=100%
Excellent

28/28=100%
Excellent

49/50=98%
Satisfactory

29/50=96%
Satisfactory

Final Pt
Satisfaction

16/22=73%
Satisfied

T2
All
subjects
had ETS
T2 done
bilaterally
(with 1
side also
T3)
Results
same as
Full study

DISCUSSION
As stated previously, conservative treatments for PH usually produces unsatisfactory
results. In the past however, that was all patients were offered. Today a multitude of conservative
and more invasive options are offered, with the most definitive treatment being the ETS.1 This
permeant surgical procedure, preformed under anesthesia and lasting less than one hour, attempts
to block signals from the sympathetic nerve trunk to sweat glands by destroying their neural
pathways through cauterization or ablation.3,6 This procedure can be confirmed in the operating
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room by an increased temperature reading on a finger prob.6 To do this a lung may be
temporarily collapsed for access to the nerve pathways in question. At the end of surgery any
residing air is evacuated from the pleural space and postoperatively patients undergo routine
“chest radiography to exclude pulmonary or pleural abnormalities.”2 Thoracic sympathectomies
had high morbidity rates in the past, that were improved as videothoracoscopy was developed.1.
Today videothoracopscopic sympathectomy is considered the “surgical technique of choice,” due
to success rates, increased safety, further development of the technique, more experienced
surgical teams, minimized invasiveness, and the esthetically pleasing result.1,2,6 Standardizing as
much of the procedure process is important to help prevent adverse outcomes.2
If the ETS does not immediately improve the PH it is usually due to sympathetic level
incomplete ablation or mistaken anatomic structure cauterization and therefore an “inadequate
sympathectomy,” which can lead to more postoperative complications.1,6 With a failed result,
most providers encourage a repeat procedure, which will usually receive the desired anhidrosis
result.1,6 Pleural adhesions from the first surgery can make a subsequent procedure difficult and
leading to possible “anatomic variations” in the surgeons technique.6 If there is still no
improvement, as seen in the Yazvek et al.1 study patient, the subject may have experienced a rare
phenomenon called the “neuroloigic escape route,” where the body’s sympathetic signals to the
sweat glands evade blockage.1 Common complications of ETS include, but are not limited to, PH
recurrence, CH, overly dryness to previously hyperhidrosis effected areas, Horner’s syndrome,
pneumothorax, subcutaneous emphysema, and/or prolonged hospital stays. All of these potential
side effects can in turn effect a patient’s perception of their procedures success. CH is the most
frequent ETS complication and the most feared due to its drastic effect on patient satisfaction
scores.1,6 CH normally occurs in the first 8 weeks to 1 year postoperative, can range from mild to
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severe enough to effect activities of daily living(ADLs), can effect multiple body regions such as
the face, axillae, trunk, abdomen, back, groin, lower limbs, and feet, and is so significant that it
has been named the “quality marker of ETS.”1,2,6
Some limitations of this review or the studies it assess include small sample size, sample
population, study length, classification definitions, and geographical location. PH occurs most
often in young healthy patients, which can be problematic due to this populations tendency to
migrate and thus not follow up with studies.6 Longer study length is shown to be more effective
in capturing true patient outcomes that may not appear in the initial time frame, but may - No
study had standardized terminology for CH, CH severity, or patient satisfaction. Yazbek et al1
study classified CH as a place of diaphoresis on the body that was not present to surgery but
didn’t distinguish if this includes only constant sweating or exclude any due to heat or exercise.
In comparison, Ong et al6 modified an international society scale to define hyperhidrosis and
labeled the most severe CH category as symptoms effecting ADLs.6 The other two studies
arbitrarily granted patient preference for CH symptom severity.1,2 All studies focused on
different body areas for CH occurrence: Yazbek et al.1 focused on the feet, legs, back, abdomen,
and gluteal region; Turkyilmaz et al.2 focused on the back, waist, groin, and legs; Ong et al.6
focused on the trunk, axillae, face and groin. Patient satisfaction was also not standardized
between questionnaires, which varied from study to study. It was unclear if dissatisfaction
included embarrassment, different diaphoresis thresholds such as being visible to others or if
frequent changing of clothing was needed. It is theorized that climate could effect CH rates, such
as those from the Yazbek et al. study1 located in Brazil and the Ong et al.6 study located in
Singapore. Areas with higher year-round temperatures may lead to more sweating in general and
thus falsely elevate CH incidences.1,6
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CONCLUSION
The results from this systemic review suggest an endoscopic thoracic sympathectomy
(ETS) at the T2 level is adequately effective in resolving palmar hyperhidrosis and resulting in
patient satisfaction. All patients in the studies except one showed immediate anhidrosis
postoperatively and no PH recurrence.1,2,6 Longer studies in the future would be even better at
observing is if PH recurrence is a possibility. Despite great initial results, many patients
developed undesirable CH symptoms without much improvement overtime. Despite high rates of
CH in the Yazbek et al.1 and Ong et al.6 studies, the overall patient satisfaction rate was high in
all three articles reviewed. Future research, on the subject of PH, would benefit and better
represent truer patient outcomes and satisfaction levels if gathered over a longer time period,
from a larger population, and/or in a less tropical study location climate. Standardizing
definitions used in all studies on PH would help to improve the significance of their results and
comparisons between similar research. Also, more tangible test results from sweat tests may help
in refining the hyperhidrosis terminology.
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